NUTRITION, SCIENCE & HEALTH
Esperer Nutrition’s commitment to health doesn’t stop with its products. Every day, we work to deliver sustainable research-based solutions which improve our quality of life. We care deeply for patients, our customers and their families. We also extend the same care to our employees and of course, the community in general. We always strive to do the right thing, pursuing the highest standards in quality, compliance, safety and performance. As a company, we embrace people from diverse backgrounds with unique perspectives, beliefs and attitudes. We believe in treating everyone equally, with dignity and respect, allowing us all to achieve our best. We prefer to think of ourselves, not as a healthcare brand, but as a brand which cares for the health and wellness of all.
The size of the clinical nutrition market in Europe was worth USD 3.82 billion in 2021 and is estimated to be growing at a CAGR of 7.17%. By 2026, the market would be worth USD 5.39 billion. The European clinical nutrition market is driven by the aging population and increased disease diagnosis. Over the last decade, the number of people diagnosed with metabolic diseases has increased, consequently increasing the number of individuals diagnosed.
Esperer Nutrition’s research team firmly consider dietary therapy to be necessary for normal growth, development and of course, overall health. It is also necessary in order to prevent acute and long-term effects of any disorder. In people with metabolic diseases, failing to follow a certain nutritional regimen can lead to problems, even demise. Esperer Nutrition's product portfolio is carefully designed for patients with metabolic abnormalities, which could in turn lead to non-communicable diseases.
Esperer Nutrition’s products are available globally. The company has special expertise in the research and development of cancer and non-communicable disease-specific enteral nutrition supplements, coupled with innovative marketing strategies.